Nasal NK/T-cell lymphoma: where are we now?
Lechowicz
Mary Jo
MJ
Hematology and Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia, USA.
D003131:Combined Modality Therapy; D006801:Humans; D054391:Lymphoma, Extranodal NK-T-Cell / Q000473:pathology / Q000628:therapy*; D009669:Nose Neoplasms / Q000473:pathology / Q000628:therapy*; D016896:Treatment Outcome